1 Out of 5 New Drugs Result in Serious Undetected Safety Issues

2
120

A study indicating that new drugs carry a 1 in 5 chance of causing unknown adverse side effects prompt a commentary in the Archives of Internal Medicine advocating for a special warning for three years after a drug’s initial approval: “New Drug: Caution Indicated.”

Article →

Of further interest:
Should new drugs wear ‘proceed with caution’ labels? (Fierce Pharma)

Previous articleFrom Fruit Flies to Kindergartners: The Science of Childhood Adversity
Next articleWill Hall speaks to the APA
Kermit Cole
Kermit Cole, MFT, founding editor of Mad in America, works in Santa Fe, New Mexico as a couples and family therapist. Inspired by Open Dialogue, he works as part of a team and consults with couples and families that have members identified as patients. His work in residential treatment — largely with severely traumatized and/or "psychotic" clients — led to an appreciation of the power and beauty of systemic philosophy and practice, as the alternative to the prevailing focus on individual pathology. A former film-maker, he has undergraduate and master's degrees in psychology from Harvard University as well as an MFT degree from the Council for Relationships in Philadelphia. Kermit leads workshops and webinars on the role of humor in psychotherapy and other human services. You can reach him at [email protected].

2 COMMENTS

  1. Absolutely absurd. Every drug, 5/5, have had serious adverse “side effects” that only came to be known after the drugs were FDA approved.

    I doubt there has ever been a drug that was released and then 20 years later there were no new significant dangers known about it.

    Report comment

  2. Right on, Jeffrey C.

    I know enough about “science” the hard way that I now know better than to read this junk as some kind of unprejudicial “truth”.

    I would be in a much better place in my life right now had my path not crossed with so much “science” in the form of polypharmacy psych drugging.

    Report comment

LEAVE A REPLY